ClinVar Miner

Submissions for variant NM_000091.5(COL4A3):c.422T>C (p.Leu141Pro) (rs10178458)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 12
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
PreventionGenetics,PreventionGenetics RCV000245465 SCV000302076 benign not specified criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000399711 SCV000428149 benign Alport syndrome 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine RCV000245465 SCV000711908 benign not specified 2016-03-21 criteria provided, single submitter clinical testing p.Leu141Pro in exon 7 of COL4A3: This variant is not expected to have clinical s ignificance because it has been identified in 91.36% (7855/8598) of East Asian c hromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute .org; dbSNP rs10178458).
GeneDx RCV000245465 SCV000716955 benign not specified 2017-05-09 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Athena Diagnostics Inc RCV000245465 SCV000841125 benign not specified 2017-04-28 criteria provided, single submitter clinical testing
Mendelics RCV000987045 SCV001136233 benign Alport syndrome, autosomal recessive 2019-05-28 criteria provided, single submitter clinical testing
Invitae RCV001515229 SCV001723260 benign not provided 2020-12-04 criteria provided, single submitter clinical testing
Nilou-Genome Lab RCV000987045 SCV001738088 benign Alport syndrome, autosomal recessive 2021-06-10 criteria provided, single submitter clinical testing
Nilou-Genome Lab RCV001658136 SCV001876528 benign Alport syndrome 3, autosomal dominant 2021-07-30 criteria provided, single submitter clinical testing
Natera, Inc. RCV000399711 SCV001454000 benign Alport syndrome 2020-09-16 no assertion criteria provided clinical testing
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV000245465 SCV001740665 benign not specified no assertion criteria provided clinical testing
Human Genetics - Radboudumc,Radboudumc RCV000245465 SCV001955488 benign not specified no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.